Please assess the completion status of the following clinical trial:

Trial Title: Transversus Abdominis Plane Blocks for Ileostomy Takedown: A Prospective Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients having an ileostomy takedown alone, on one side of abdomen~2. Ages 18-80 inclusive~3. English speaking~4. BMI less than 40~5. Ability to understand verbal pain scale~6. American Society of Anesthesiologists (ASA) Physical Status 1-3~Exclusion Criteria:~1. Allergy to local anesthetics~2. History of recent/current local or generalized infection~3. Immunocompromised~4. Significant psychiatric disease~5. History of opioid dependence~6. Pregnancy or lactation~7. A prisoner.~8. Significant liver disease~9. Contraindication to ondansetron or dexamethasone~10. Clinically significant cardiac or pulmonary disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- TAP block group (Type: EXPERIMENTAL): Patients in this group will have a preoperative, ultrasound guided injection of 30ml of 0.375% bupivacaine into the muscle plane between the transversus abdominis muscle and internal oblique muscles.
- Placebo (Type: PLACEBO_COMPARATOR): Patients in this group will have an ultrasound guided subcutaneous injection of 30 ml of sterile preservative free saline.

Based on this trial design, predict the completion outcome and termination type (if applicable).